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Probiotics are used by millions of people for their docu-
mented or anticipated health benefits. They usu-ally
belong to the genera lactobacilli and bifidobacteria and
are part of the normal flora. They have been studied in
a wide variety of diseases and in the prevention of
inflammatory and infectious dis-eases. The safety of pro-
biotics has been approached by evaluating retrospective
reviews, prospective studies and case reports. Different
probiotic bacteria have shown safe use in critically ill
children, patients with Clostridium diffi-cile diarrhoea,
Crohn’s disease, children attending day care centers,
patients with rotavirus diarrhoea, with Helicobacter
pylori infection, with irritable bowel syndrome, with
HIV infection–associated diar-rhoea, with necrotizing
enterocolitis, in intensive care units. Lactobacillus rham-
nosus GG (LGG) is the most studied probiotic with
most thorough information on safety aspects. Lactoba-
cilli have traditionally been consumed in fermented
dairy foods in many countries and have during the last
20 years been introduced into dairy products. A possible
impact of LGG on occurrence of bloodstream infections
by lactobacilli was evaluated. In 1990 LGG was intro-
duced in dairy products in Finland, after a slow start a
sharp rise to 6L/person/year in 1999 emerged. Since
1990 lactobacillus isolates from blood culture specimens
have been performed at Helsinki University Central
Hospital laboratory and a national surveillance of all
bloodstream infections. Of isolates originally reported to
be Lactobacillus species, the percentage among all blood
cultures was 0.021 and percentage among positive blood
cultures was 0.19 and in the national surveillance regis-
ter 0.24. During this 10 year in-terval no increase in
these figures could be observed, despite a strong
increase in consumption. Lactobacillus infections are
rare despite abundancy in gut normal flora and wide-
spread use. Prudence is needed when used for immuno-
compromised patients, premature infants, short bowel
syndrome. The benefits seem to outweigh the potential
for septic infections.
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